Tuesday, May 21

No Contaminated Johnson & Johnson Cough Syrup in Ghana -FDA

The Food and Drugs Authority (FDA) has taken proactive measures to prevent a batch of children’s cough syrup manufactured by Johnson & Johnson, which has been recalled in six African countries, from entering Ghana.

This action follows warnings from Nigeria’s drug agency that the syrup contained high levels of a toxic and potentially fatal substance, prompting recalls in Tanzania and Zimbabwe as a precautionary measure. However, Zimbabwe’s Medicines Control Authority stated that there was no record of the syrup being imported into the country.

In response to these developments, the FDA released a statement last Friday (12 April), reassuring the public that the contaminated syrup, identified by LOT No. 329304, is not available on the Ghanaian market. The FDA conducted a thorough review of importation data from 2021, which confirmed the absence of the affected lot in Ghana.

“The FDA hereby assures the public that LOT No. 329304 is not available on our market, having reviewed all the data on the importation of the product to Ghana from 2021,” the statement said.

Furthermore, the FDA has intensified surveillance efforts at ports to prevent the entry of LOT No. 329304 into Ghana. The authority urged the public to remain vigilant and report any information regarding the affected lot of Benylin Paediatric Syrup.

The FDA’s swift response demonstrates its commitment to ensuring the safety and well-being of the Ghanaian population by preventing the circulation of potentially harmful products in the market.